✨
AI Summary
- TC BioPharm CEO Bryan Kobel explains the advantages of gamma delta T cells (GDT) for cell therapy.
- He discusses the company's in-house clinical trial management and its unique challenges.
- The episode delves into GDT cells as a promising therapeutic vehicle.
Guests on This Episode
BK
Bryan Kobel
1 podcast appearance